Compare UA & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UA | TXG |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | 14400 | N/A |
| Industry | Apparel | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.8B |
| IPO Year | N/A | 2019 |
| Metric | UA | TXG |
|---|---|---|
| Price | $5.95 | $17.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $17.18 |
| AVG Volume (30 Days) | ★ 2.5M | 2.2M |
| Earning Date | 02-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.72 | $7.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $3.95 | $6.78 |
| 52 Week High | $7.91 | $23.56 |
| Indicator | UA | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 38.15 |
| Support Level | $5.88 | $11.62 |
| Resistance Level | $6.43 | $17.33 |
| Average True Range (ATR) | 0.28 | 1.34 |
| MACD | -0.14 | -0.50 |
| Stochastic Oscillator | 3.61 | 18.38 |
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).